See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Vatican
Volodymyr Zelenskyy
Ukraine War
Olaf Scholz
Donald Trump
Elon Musk
Israel-Hamas Conflict
Basketball
Vladimir Putin
Manchester City
Hamas
Published • loading... • Updated

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Summary by biopharminternational.com
Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
biopharminternational.combiopharminternational.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharminternational.com broke the news in on Wednesday, January 15, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Basel

Basel

News
For You
Search
BlindspotLocal